全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用：99美元
投递稿件

查看量下载量

相关文章

更多...

Phenotypic Evidence of Emerging Ivermectin Resistance in Onchocerca volvulus

DOI: 10.1371/journal.pntd.0000998

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Ivermectin (IVM) has been used in Ghana for over two decades for onchocerciasis control. In recent years there have been reports of persistent microfilaridermias despite multiple treatments. This has necessitated a reexamination of its microfilaricidal and suppressive effects on reproduction in the adult female Onchocerca volvulus. In an initial study, we demonstrated the continued potent microfilaricidal effect of IVM. However, we also found communities in which the skin microfilarial repopulation rates at days 90 and 180 were much higher than expected. In this follow up study we have investigated the reproductive response of female worms to multiple treatments with IVM. Methods and Findings The parasitological responses to IVM in two hundred and sixty-eight microfilaridermic subjects from nine communities that had received 10 to 19 annual doses of IVM treatment and one pre-study IVM-na？ve community were followed. Skin snips were taken 364 days after the initial IVM treatment during the study to determine the microfilaria (mf) recovery rate. Nodules were excised and skin snips taken 90 days following a second study IVM treatment. Nodule and worm density and the reproductive status of female worms were determined. On the basis of skin mf repopulation and skin mf recovery rates we defined three categories of response—good, intermediate and poor—and also determined that approximately 25% of subjects in the study carried adult female worms that responded suboptimally to IVM. Stratification of the female worms by morphological age and microfilarial content showed that almost 90% of the worms were older or middle aged and that most of the mf were produced by the middle aged and older worms previously exposed to multiple treatments with little contribution from young worms derived from ongoing transmission. Conclusions The results confirm that in some communities adult female worms were non-responsive or resistant to the anti-fecundity effects of multiple treatments with IVM. A scheme of the varied responses of the adult female worm to multiple treatments is proposed.

 References

[1]  Duke BO, Zea-Flores G, Munoz B (1991) The embryogenesis of Onchocerca volvulus over the first year after a single dose of ivermectin. Trop Med Parasitol 42: 175–180.
[2]  World Health Organization (1995) Onchocerciasis and its control: Report of a WHO Expert Committee on Onchocerciasis Control. Technical Report Series No. 852. Geneva: WHO.
[3]  Kl？ger S, Whitworth JA, Post RJ, Chavasse DC, Downham MD (1993) How long do the effects of ivermectin on adult Onchocerca volvulus persist? Trop Med Parasitol 44: 305–310.
[4]  Duke BOL, Zea-Flores G, Castro J, Cupp EW, Munoz B (1990) Effect of multiple monthly doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 43: 657–664.
[5]  Duke BO, Pacqué MC, Mu？oz B, Greene BM, Taylor HR (1991) Viability of adult Onchocerca volvulus after six 2-weekly doses of ivermectin. Bull World Health Organ 69: 163–168.
[6]  Duke BO, Zea-Flores G, Castro J, Cupp EW, Munoz B (1992) Effects of three-month doses of ivermectin on adult Onchocerca volvulus. Am J Trop Med Hyg 46: 189–194.
[7]  Chavasse DC, Post RJ, Davies JB, Whitworth JA (1993) Absence of sperm from the seminal receptacle of female Onchocerca volvulus following multiple doses of ivermectin. Trop Med Parasitol 44: 155–158.
[8]  Gardon J, Boussinesq M, Kamgno J, Gardon-Wendel N, Demanga-Ngangue , et al. (2002) Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet 360: 203–210. doi: 10.1016/S0140-6736(02)09456-4
[9]  Plaisier AP, Alley ES, Boatin BA, van Oortmarssen GJ, Remme H, et al. (1995) Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the onchocerciasis control program in west-Africa. J Inf Dis 172: 204–210. doi: 10.1093/infdis/172.1.204
[10]  Kl？ger SL, Whitworth JAG, Downham MD (1996) Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin. Trop Med Int Health 1: 581–589. doi: 10.1111/j.1365-3156.1996.tb00083.x
[11]  Chavasse DC, Post RJ, Lemoh PA, Whitworth JA (1992) The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone. Trop Med Parasitol 43: 256–262.
[12]  Bottomley C, Isham V, Collins RC, Basá？ez M-G (2008) Rates of microfilarial production by Onchocerca volvulus are not cumulatively reduced by multiple ivermectin treatments. Parasitology 135: 1571–1581. doi: 10.1017/S0031182008000425
[13]  Awadzi K, Boakye DA, Edwards G, Opoku NO, Attah SK, et al. (2004a) An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 231–249. doi: 10.1179/000349804225003253
[14]  Awadzi K, Attah SK, Addy ET, Opoku NO, Quartey BT, et al. (2004b) Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana. Ann Trop Med Parasitol 98: 359–370. doi: 10.1179/000349804225003442
[15]  Osei-Atweneboana MY, Eng JK, Boakye DA, Gyapong JO, Prichard RK (2007) Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study. Lancet 369: 2021–2029. doi: 10.1016/S0140-6736(07)60942-8
[16]  Anziani OS, Suarez V, Guglielmone AA, Grande H, Coles GC (2004) Resistance to benzimidazole and macrocyclic lactone anthelmintics in cattle nematodes in Argentina. Vet Parasitol 122: 303–306. doi: 10.1016/j.vetpar.2004.05.018
[17]  Kotze AC, Dobson RJ, Tyrrell KL, Stein PA (2002) High-level ivermectin resistance in a field isolate of Haemonchus contortus associated with a low level of resistance in the larval stage: implications for resistance detection. Vet Parasitol 108: 255–263. doi: 10.1016/S0304-4017(02)00200-5
[18]  Edward CL, Hoffmann AA (2008) Ivermectin resistance in a horse in Australia. Vet Rec 162: 56–57. doi: 10.1136/vr.162.2.56
[19]  Prichard RK (2001) Genetic variability following selection of Haemonchus contortus with anthelmintics. Trends Parasitol 132: 223–239. doi: 10.1016/s1471-4922(01)01983-3
[20]  Alleman MM, Twum-Danso NA, Thylefors BI (2006) The Mectizan Donation Program - highlights from 2005. Filaria J 27: 5–11.
[21]  Eng JK, Prichard RK (2005) A comparison of genetic polymorphism in populations of Onchocerca volvulus from untreated- and ivermectin-treated patients. Mol Biochem Parasitol 142: 193–202. doi: 10.1016/j.molbiopara.2005.01.021
[22]  Bourguinat C, Pion SD, Kamgno J, Gardon J, Duke BO, et al. (2007) Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis 1: 12–22.
[23]  Ardelli BF, Guerriero SB, Prichard RK (2005) Genomic organization and effects of ivermectin selection on Onchocerca volvulus P-glycoprotein. Mol Biochem Parasitol 143: 58–66. doi: 10.1016/j.molbiopara.2005.05.006
[24]  Eng JK, Blackhall WJ, Osei-Atweneboana MY, Bourguinat C, Galazzo D, et al. (2006) Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. Mol Biochem Parasitol 50: 229–235. doi: 10.1016/j.molbiopara.2006.08.007
[25]  Specht S, Brattig N, Büttner M, Büttner DW (2009) Criteria for the differentiation between young and old Onchocerca volvulus filariae. Parasitol Res 105: 1531–1538. doi: 10.1007/s00436-009-1588-5
[26]  Schulz-Key H (1988) The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug trials. Trop Med Parasitol 39: 423–440.
[27]  Schulz-Key H, Albiez EJ, Büttner DW (1977) Isolation of living adult Onchocerca volvulus from nodules. Tropenmed Parasitol 28: 428–430.
[28]  Schulz-Key H, Jean B, Albiez EJ (1980) Investigations on female Onchocerca volvulus for the evaluation of drug trials. Tropenmed Parasitol 31: 34–40.
[29]  Alley ES, Plaisier AP, Boatin BA, Dadzie KY, Remme J, et al. (1994) The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana. Trans R Soc Trop Med Hyg 88: 581–584. doi: 10.1016/0035-9203(94)90172-4
[30]  Kennedy MH, Bertocchi I, Hopkins AD, Meredith SE (2002) The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic. Ann Trop Med Parasitol 96: 297–307. doi: 10.1179/000349802125000736
[31]  Churcher TS, Pion SDS, Osei-Atweneboana MY, Prichard RK, Awadzi K, et al. (2009) Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci, USA 106(39): 16716–16721. doi: 10.1073/pnas.0906176106
[32]  African Programme for Onchocerciasis Control (2008) Report of the twenty sixth session of the Technical Consultative committee. Ouagadougou: APOC. Available from http://www.who.int/apoc/about/structure/？tcc/Final_Report_TCC_26_English_23_05_08？.pdf.
[33]  Remme JHF, Amazigo U, Engels D, Barryson A, Yameogo L (2007) Efficacy of ivermectin against Onchocerca volvulus in Ghana. Lancet 370: 1123–1124. doi: 10.1016/S0140-6736(07)61503-7
[34]  Ali MMM, Mukhtar MM, Baraka OZ, Homeida MMA, Kheir MM, et al. (2002) Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. Acta Trop 84: 49–53. doi: 10.1016/S0001-706X(02)00117-1
[35]  Thylefors B, Brinkmann UK (1977) The microfilarial load in the anterior segment of the eye. A parameter of the intensity of infection of onchocerciasis. Bull of the World Health Org 55: 731–737.
[36]  Remme J, Dadzie KY, Rolland A, Thylefors B (1989) Ocular onchocerciasis and intensity of infection in the community. I. West African savanna. Trop Med Parasitol 40: 340–347.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133